Teladoc Health, Inc. TDOC
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 45.60% | -19.13% | 31.37% | 48.06% | -48.78% |
| Total Depreciation and Amortization | 10.98% | 10.13% | 16.22% | 7.02% | -10.86% |
| Total Amortization of Deferred Charges | -13.14% | -17.18% | -9.11% | 10.16% | 17.92% |
| Total Other Non-Cash Items | -58.32% | -29.80% | -75.02% | -70.02% | -12.33% |
| Change in Net Operating Assets | 15.44% | -99.20% | 12.00% | -61.83% | 66.26% |
| Cash from Operations | 7.25% | -29.28% | -40.22% | 2.14% | -9.90% |
| Capital Expenditure | 46.75% | 26.81% | 39.10% | 57.29% | -42.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.77% | 29.57% | 37.67% | -34.82% | -0.97% |
| Cash from Investing | 36.74% | 30.33% | 70.37% | -15.77% | -56.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -19.34% | 25.72% | -48.11% | -41.39% | -45.98% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -99.43% | -1,486.49% |
| Cash from Financing | 111.61% | 100.16% | -418.47% | -46.36% | -614.61% |
| Foreign Exchange rate Adjustments | -51.85% | -107.51% | -156.21% | 107.99% | -118.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 62.05% | 104.60% | 71.10% | 0.69% | -42.78% |